Works matching IS 2365421X AND DT 2024 AND VI 8 AND IP 1
Results: 2
Preclinical evaluation of an <sup>18</sup>F-labeled N<sup>ε</sup>-acryloyllysine piperazide for covalent targeting of transglutaminase 2.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00231-1
- By:
- Publication type:
- Article
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00230-2
- By:
- Publication type:
- Article